Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoya Inagawa

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsSoichiro Shimizu, Shoya Inagawa, Ryo Yamamoto, et al.
Plos One|September 9, 2024
Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodiesYuta Inagawa, Shoya Inagawa, Naoto Takenoshita, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 7, 2026
Eligibility for Anti-Amyloid-β Monoclonal Antibodies in Patients With Primary Progressive Aphasia due to Alzheimer's Disease in JapanShoya Inagawa, Yuta Inagawa, Akito Tsugawa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersYuta Inagawa, Yuki Miyagi, Shoya Inagawa, et al.
Journal of Alzheimer'S Disease : JAD|February 24, 2026
Evaluation of the effects of lecanemab treatment on brain atrophy using voxel-based specific regional analysis system for Alzheimer's diseaseYuta Inagawa, Tomoki Kamiya, Yuki Miyagi, et al.
Biomolecules|October 29, 2025
Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer's DiseaseKazuya Igarashi, Tamao Tsukie, Kazuo Washiyama, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|September 19, 2023
Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodiesRyo Yamamoto, Naoto Takenoshita, Yuta Inagawa, et al.
Parkinsonism & Related Disorders|January 22, 2026
Comparative pharmacokinetics of levodopa-carbidopa intestinal gel infusion and foslevodopa-foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's diseaseYohei Mukai, Junko Takei, Juri Nomoto, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsSoichiro Shimizu, Shoya Inagawa, Ryo Yamamoto, et al.
Plos One|September 9, 2024
Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodiesYuta Inagawa, Shoya Inagawa, Naoto Takenoshita, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 7, 2026
Eligibility for Anti-Amyloid-β Monoclonal Antibodies in Patients With Primary Progressive Aphasia due to Alzheimer's Disease in JapanShoya Inagawa, Yuta Inagawa, Akito Tsugawa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersYuta Inagawa, Yuki Miyagi, Shoya Inagawa, et al.
Journal of Alzheimer'S Disease : JAD|February 24, 2026
Evaluation of the effects of lecanemab treatment on brain atrophy using voxel-based specific regional analysis system for Alzheimer's diseaseYuta Inagawa, Tomoki Kamiya, Yuki Miyagi, et al.
Biomolecules|October 29, 2025
Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer's DiseaseKazuya Igarashi, Tamao Tsukie, Kazuo Washiyama, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|September 19, 2023
Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodiesRyo Yamamoto, Naoto Takenoshita, Yuta Inagawa, et al.
Parkinsonism & Related Disorders|January 22, 2026
Comparative pharmacokinetics of levodopa-carbidopa intestinal gel infusion and foslevodopa-foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's diseaseYohei Mukai, Junko Takei, Juri Nomoto, et al.
Pageof 1